Ausdal Financial Partners Inc. Sells 3,115 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Ausdal Financial Partners cut its UnitedHealth Group position by 15.6% in the second quarter, selling 3,115 shares and retaining 16,887 shares valued at approximately $7.0 million. Institutional investors collectively own 87.86% of the company.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $456.56. Recent target increases included RBC at $478, UBS at $490, and DA Davidson at $512.
• UnitedHealth reported quarterly EPS of $6.38, exceeding estimates of $4.94, and revenue of $112.03 billion. The company also declared a quarterly dividend of $2.32 per share, equivalent to a 2.4% annualized yield.

Ausdal Financial Partners Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 15.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,887 shares of the healthcare conglomerate's stock after selling 3,115 shares during the quarter. Ausdal Financial Partners Inc.'s holdings in UnitedHealth Group were worth $7,018,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Sarver Vrooman Wealth Advisors purchased a new stake in UnitedHealth Group in the fourth quarter valued at about $25,000. Aberdeen Wealth Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter valued at about $31,000. Anfield Capital Management LLC boosted its stake in UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock worth $26,000 after purchasing an additional 55 shares in the last quarter. Joseph Group Capital Management acquired a new position in UnitedHealth Group during the 4th quarter valued at approximately $27,000. Finally, Nalls Sherbakoff Group LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $27,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 1,169 shares of the company's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company's stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.19% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on UNH shares. Royal Bank Of Canada upped their target price on UnitedHealth Group from $463.00 to $478.00 and gave the company an "outperform" rating in a research report on Friday, July 17th. Wells Fargo & Company increased their price objective on UnitedHealth Group from $397.00 to $485.00 and gave the company an "overweight" rating in a report on Monday, July 13th. DA Davidson set a $512.00 target price on UnitedHealth Group in a report on Tuesday, July 21st. UBS Group increased their price target on shares of UnitedHealth Group from $460.00 to $490.00 and gave the stock a "buy" rating in a report on Friday, July 17th. Finally, Zacks Research raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Monday, July 13th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $456.56.

UnitedHealth Group Trading Down 1.6%

Shares of NYSE:UNH opened at $394.57 on Friday. The company has a market capitalization of $354.16 billion, a PE ratio of 25.39, a PEG ratio of 1.39 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $255.96 and a 12-month high of $461.62. The business has a 50 day moving average of $413.42 and a two-hundred day moving average of $359.88. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.94 by $1.44. The firm had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business's quarterly revenue was up .4% on a year-over-year basis. During the same period in the previous year, the firm earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 19.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group's dividend payout ratio (DPR) is 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source